Cd logo

Augmentin 500mg/125mg and/or Equivalents

Top Brand Choice

Augmentin 500mg/125mg

No image thumb

Marketed as Augmentin in New Zealand

Manufactured by: Glaxosmithkline

This product is offered for sale by a Licensed Pharmacy located in New Zealand

From $2.02 USD/tablet

CAN NOT BE SPLIT Must be taken in existing form.

Prescription Required
Top Generic Choice

Amoxicillin/Clavulanate 500mg/125mg (generic equivalent to Clavulin)

Amoxicillin clavulanate generic equivalent to clavulin 500mg 125mg 20503

Product of the United Kingdom

Manufactured by: Various Generic Manufacturers

This product is offered for sale by a Licensed Pharmacy located in the United Kingdom

From $1.17 USD/tablet

MAY BE SPLIT May be split and taken at half the dose listed.

Prescription Required

More Brand Products

Product Lowest Unit Price
Augmentin 500mg/125mg
Marketed as Clavulin in CanadaManufactured by: Glaxosmithkline
This product is currently on back order.
Augmentin 500mg/125mg
Marketed as Clavulin in CanadaManufactured by: Glaxosmithkline
$3.11 USD/tablet
Augmentin 500mg/125mg
Product of the United KingdomManufactured by: Glaxosmithkline
$2.51 USD/tablet
Augmentin 500mg/125mg
Marketed as Augmentin in AustraliaManufactured by: Aspen Pharmacare
$2.91 USD/tablet
Augmentin 500mg/125mg
Marketed as Augmentin in New ZealandManufactured by: Glaxosmithkline
$2.02 USD/tablet
Augmentin 500mg/125mg
Product of the United KingdomManufactured by: Glaxosmithkline
$2.51 USD/tablet

More Generic Products

Product Lowest Unit Price
Amoxicillin/Clavulanate 500mg/125mg (generic equivalent to Augmentin)
Product of CanadaManufactured by: Apotex
$1.71 USD/tablet
Alphaclav 500mg/125mg (generic equivalent to Augmentin 500mg/125mg )
Product of AustraliaManufactured by: Alphapharm Pty Limited
$1.68 USD/tablet
Amoxicillin/Clavulanate 500mg/125mg (generic equivalent to Clavulin)
Product of the United KingdomManufactured by: Various Generic Manufacturers
$1.17 USD/tablet

Augmentin and/or Equivalents warnings, side-effects and general information


Share on Facebook Share on Twitter